Delivery Order SPE2DB20D1110-SPE2DB25FK21C

Award Date 6/17/25
Potential Completion Date 6/18/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Corlanor 5 mg tablets. The contract has a ceiling value of $1,429.63 and a period of performance ending on May 14, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Corlanor 5 mg tablets. The contract has a firm fixed price of $3,754.23 and an ultimate completion date of June 24, 2025. The award is not set aside and provides for the delivery of pharmaceutical products to support military and government healthcare programs. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication Corlanor 5 mg tablets. The contract has a ceiling value of $5,070.39 and is a firm fixed-price delivery order without any set-aside designation, indicating open competition. The contract has an ultimate completion date of May 2, 2025 and was awarded on May 1, 2025. AmerisourceBergen Drug Corp, based in...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,726.79, is for the supply of Corlanor 5 mg tablets. The order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,589.46, is for the supply of Corlanor 5 mg tablets in 60-count bottles. The contract has an ultimate completion date of January 28, 2025 and is a firm fixed-price delivery order contract. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,809.83, is for the supply of 4,568,108,411 units of the medication Corlanor 5 mg tablet. The contract has an ultimate completion date of May 2, 2025 and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,637.56 firm fixed-price contract is for the supply of the prescription medication Corlanor in 5 mg tablet form. The contract has an ultimate completion date of October 22, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $58,335.30, is for the delivery of Corlanor 5 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of Corlanor 5 mg tablets, a prescription medication, to DLA Troop Support Medical facilities supporting the Department of Defense. The contract has a ceiling value of $3,749.41 and a performance period through March 13, 2024. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CORLANOR 5 MG TABLET 60S. The contract has a ceiling value of $2,114.52 and an ultimate completion date of August 7, 2024. It is a firm fixed-price contract with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through...
  • SPE2DB20D1110
    Indefinite Delivery Contract
  • SPE2DB20D1110-SPE2DB25FK21C
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication Corlanor 5 mg tablets. The contract has a firm fixed price of $3,995.82 and a period of performance through June 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support vehicle for military and other government healthcare programs through December 2026.

Generated 9/16/25, 10:01 AM